ARTICLE | Product Development
Treating HAE
November 1, 2004 8:00 AM UTC
In normal patients, C1 esterase inhibitor can normalize inflammation by intervening to slow formation of prekallikrien from Factor XIIa or by inhibiting conversion of HMW-kininogen. Kallikrein mediate...